Eam Global Investors LLC Champions Oncology, Inc. Transaction History

Eam Global Investors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$7.89 - $12.23 $908,470 - $1.41 Million	-115,142 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.29 - $15.27 $67,352 - $141,079	9,239 Added 8.72%	115,142 $899,000
Q3 2018 Nov 08, 2018	BUY	$5.82 - $17.47 $616,355 - $1.85 Million	105,903 New	105,903 $1.85 Million

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $113M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.